Application of nano‐radiosensitizers in combination cancer therapy

Author:

Varzandeh Mohammad1,Sabouri Leila23,Mansouri Vahid34,Gharibshahian Maliheh35,Beheshtizadeh Nima36ORCID,Hamblin Michael R.78,Rezaei Nima8910ORCID

Affiliation:

1. Department of Materials Engineering Isfahan University of Technology Isfahan Iran

2. AmitisGen TECH Dev Group Tehran Iran

3. Regenerative Medicine Group (REMED) Universal Scientific Education and Research Network (USERN) Tehran Iran

4. Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences Tehran Iran

5. Student Research Committee School of Medicine, Shahroud University of Medical Sciences Shahroud Iran

6. Department of Tissue Engineering School of Advanced Technologies in Medicine, Tehran University of Medical Sciences Tehran Iran

7. Laser Research Center, Faculty of Health Science University of Johannesburg Doornfontein South Africa

8. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN) Tehran Iran

9. Research Center for Immunodeficiencies Children's Medical Center, Tehran University of Medical Sciences Tehran Iran

10. Department of Immunology School of Medicine, Tehran University of Medical Sciences Tehran Iran

Abstract

AbstractRadiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano‐radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects.

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3